Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease

Delaney, 2006, Is society losing control of the medical research agenda?, BMJ, 332, 1063, 10.1136/bmj.38771.471563.80 Jun, 2015, Assessing the extent to which current clinical research is consistent with patient priorities: a scoping review using a case study in patients on or nearing dialysis, Can J Kidney Health Dis, 2, 35, 10.1186/s40697-015-0070-9 Crowe, 2015, Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch, Research Involvement Engagement, 1, 2, 10.1186/s40900-015-0003-x Tallon, 2000, Relation between agendas of the research community and the research consumer, Lancet, 355, 2037, 10.1016/S0140-6736(00)02351-5 Oliver, 2004, Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach, Health Technol Assess, 8, 1, 10.3310/hta8150 Boivin, 2014, Involving patients in setting priorities for healthcare improvement: a cluster randomized trial, Implement Sci, 9, 24, 10.1186/1748-5908-9-24 Buckley, 2011, Case study: a patient-clinician collaboration that identified and prioritized evidence gaps and stimulated research development, J Clin Epidemiol, 66, 483, 10.1016/j.jclinepi.2011.03.016 Coleman, 2011, Increasing incidence of Barrett's oesophagus: a population-based study, Eur J Epidemiol, 26, 739, 10.1007/s10654-011-9596-z Eloubeidi, 2003, Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?, Am J Gastroenterol, 98, 1627, 10.1111/j.1572-0241.2003.07454.x Jones, 1995, Consensus methods for medical and health services research, BMJ, 311, 376, 10.1136/bmj.311.7001.376 Wiseman, 2011, Risk factors for neoplastic progression in Barrett's esophagus, World J Gastroenterol, 17, 3672, 10.3748/wjg.v17.i32.3672 Old, 2015, Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial, J Med Screen, 22, 158, 10.1177/0969141315575052 Solaymani-Dodaran, 2013, Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study, Gastroenterology, 144, 1375, 10.1053/j.gastro.2013.02.050 Caygill, 2012, Mortality in Barrett's esophagus: three decades of experience at a single center, Endoscopy, 44, 892, 10.1055/s-0032-1309842 Gordon, 2013, Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus, Gastrointest Endosc, 79, 242, 10.1016/j.gie.2013.07.046 Fitzgerald, 2013, British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus, Gut, 63, 7, 10.1136/gutjnl-2013-305372 Bennett, 2015, BOB CAT: a large-scale review and delphi consensus for management of Barrett's esophagus with no dysplasia, indefinite for, or low-grade dysplasia, Am J Gastroenterol, 110, 662, 10.1038/ajg.2015.55 Findlay, 2015, Genetic biomarkers of Barrett's esophagus susceptibility and progression to dysplasia and cancer: a systematic review and meta-analysis, Dig Dis Sci, 61, 25, 10.1007/s10620-015-3884-5 Gregson, 2016, Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma, Br J Cancer, 115, 403, 10.1038/bjc.2016.219 Mandal, 2003, Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK, Aliment Pharmacol Ther, 17, 1319, 10.1046/j.1365-2036.2003.01586.x Reimer, 2013, Safety of long-term PPI therapy, Best Pract Res Clin Gastroenterol, 27, 443, 10.1016/j.bpg.2013.06.001 Heidelbaugh, 2012, Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?, Int J Clin Pract, 66, 582, 10.1111/j.1742-1241.2012.02921.x Jo, 2014, A proton pump inhibitor's effect on bone metabolism mediated by osteoclast action in old age: a prospective randomized study, Gut Liver, 9, 607 Hopkins, 2015, Update on novel endoscopic therapies to treat gastroesophageal reflux disease: a review, World J Gastrointest Endosc, 7, 1039, 10.4253/wjge.v7.i11.1039 Das, 2016, Is the Stretta procedure as effective as the best medical and surgical treatments for gastro-oesophageal reflux disease? A best evidence topic, Int J Surg, 30, 19, 10.1016/j.ijsu.2016.03.062 Lipka, 2014, No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 13, 1058, 10.1016/j.cgh.2014.10.013 Liang, 2014, Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study, BMC Gastroenterol, 14, 178, 10.1186/1471-230X-14-178 Saino, 2015, Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement, J Laparoendosc Adv Surg Tech A, 25, 787, 10.1089/lap.2015.0394 Soffer, 2016, Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors, World J Gastrointest Pharmacol Ther, 7, 145, 10.4292/wjgpt.v7.i1.145 Rodríguez, 2014, Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease, Surgery, 157, 556, 10.1016/j.surg.2014.10.012 Kappelle, 2015, Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease—interim results of an international multicentre trial, Aliment Pharmacol Ther, 42, 614, 10.1111/apt.13306 Testoni, 2016, Transoral incisionless fundoplication for gastro-esophageal reflux disease: techniques and outcomes, World J Gastrointest Pharmacol Ther, 7, 179, 10.4292/wjgpt.v7.i2.179 Håkansson, 2015, Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD, Aliment Pharmacol Ther, 42, 1261, 10.1111/apt.13427 Haidry, 2015, Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry, Endoscopy, 47, 980, 10.1055/s-0034-1392414 Krishnamoorthi, 2016, Risk of recurrence of Barrett's esophagus after successful endoscopic therapy, Gastrointest Endosc, 83, 1090, 10.1016/j.gie.2016.02.009 Belghazi, 2016, Current controversies in radiofrequency ablation therapy for Barrett's esophagus, Curr Treat Options Gastroenterol, 14, 1, 10.1007/s11938-016-0080-4 Shaheen, 2010, Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia, Gastrointest Endosc, 71, 680, 10.1016/j.gie.2010.01.018 Peerally, 2016, Gastrointest Endosc, 83, AB151, 10.1016/j.gie.2016.03.105 Pasricha, 2014, Durability and predictors of successful radiofrequency ablation for Barrett's esophagus, Clin Gastroenterol Hepatol, 12, 1840, 10.1016/j.cgh.2014.04.034 Jankowski, 2006, Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base, BMJ, 332, 1512, 10.1136/bmj.332.7556.1512 Das, 2009, Chemoprevention of oesophageal cancer and the AspECT trial, Recent Results Cancer Res, 181, 161, 10.1007/978-3-540-69297-3_15 Boivin, 2014, What are the key ingredients for effective public involvement in health care improvement and policy decisions? A randomized trial process evaluation, Milbank Q, 92, 319, 10.1111/1468-0009.12060 Hart, 2016, What are the top 10 research questions in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind Alliance, J Crohns Colitis, 11, 204, 10.1093/ecco-jcc/jjw144 Deane, 2014, Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease, BMJ Open, 4, e006434, 10.1136/bmjopen-2014-006434 Elwyn, 2010, Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions, J Eval Clin Pract, 16, 627